tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GYRE Stock Latest News

Buy Rating for Gyre Therapeutics Driven by Phase 3 Trial Progress and Strategic Asset Valuation
RatingsBuy Rating for Gyre Therapeutics Driven by Phase 3 Trial Progress and Strategic Asset Valuation
11d ago
GYRE
Gyre Therapeutics completes enrollment in Phase 3 trial of Pirfenidone capsules
PremiumThe Fly
Gyre Therapeutics completes enrollment in Phase 3 trial of Pirfenidone capsules
11d ago
GYRE
Gyre Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Gyre Therapeutics initiated with a Buy at Jefferies
16d ago
GYRE
Gyre Therapeutics Announces Positive Phase 3 Results
PremiumCompany Announcements
Gyre Therapeutics Announces Positive Phase 3 Results
2M ago
8K
GYRE
Gyre Therapeutics: A Compelling Buy with Potential Blockbuster Drug Hydronidone Targeting Liver Fibrosis
PremiumRatings
Gyre Therapeutics: A Compelling Buy with Potential Blockbuster Drug Hydronidone Targeting Liver Fibrosis
2M ago
GYRE
Gyre Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyGyre Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
GYRE
Gyre Therapeutics Appoints Dan Weng to Board
Premium
Company Announcements
Gyre Therapeutics Appoints Dan Weng to Board
2M ago
8K
GYRE
Gyre Therapeutics appoints Dan Weng to board of directors
Premium
The Fly
Gyre Therapeutics appoints Dan Weng to board of directors
2M ago
GYRE
Gyre Therapeutics Reports Q2 2025 Earnings and Strategic Updates
PremiumCompany Announcements
Gyre Therapeutics Reports Q2 2025 Earnings and Strategic Updates
3M ago
GYRE
Gyre Therapeutics Appoints Ping Zhang as Interim CEO
PremiumCompany Announcements
Gyre Therapeutics Appoints Ping Zhang as Interim CEO
3M ago
8K
GYRE
Gyre Therapeutics CEO Han Ying steps down
PremiumThe Fly
Gyre Therapeutics CEO Han Ying steps down
3M ago
GYRE
Innovative Strategy and Strong Pipeline Position Gyre Therapeutics for Market Success
PremiumRatings
Innovative Strategy and Strong Pipeline Position Gyre Therapeutics for Market Success
4M ago
GYRE
Gyre Therapeutics announces first doing in Phase 1 trial of F230
PremiumThe FlyGyre Therapeutics announces first doing in Phase 1 trial of F230
5M ago
GYRE
Gyre Therapeutics Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
Gyre Therapeutics Holds 2025 Annual Stockholders Meeting
5M ago
8K
GYRE
Gyre Therapeutics Announces Stock Offering Agreement
Premium
Company Announcements
Gyre Therapeutics Announces Stock Offering Agreement
5M ago
8K
GYRE
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
PremiumThe Fly
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
5M ago
X
BAH
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
5M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
5M ago
GYRE
Gyre Therapeutics 2.22M share Spot Secondary priced at $9.00
PremiumThe Fly
Gyre Therapeutics 2.22M share Spot Secondary priced at $9.00
5M ago
GYRE
Closing Bell Movers: Deckers falls 15% on weak guidance; Nuclear names rally
PremiumThe FlyClosing Bell Movers: Deckers falls 15% on weak guidance; Nuclear names rally
5M ago
NNE
SMR
Gyre Therapeutics Achieves Key Milestone in Phase 3 Trial
Premium
Company Announcements
Gyre Therapeutics Achieves Key Milestone in Phase 3 Trial
5M ago
8K
GYRE
Gyre Therapeutics announces Hydronidone trial met primary endpoint
Premium
The Fly
Gyre Therapeutics announces Hydronidone trial met primary endpoint
5M ago
GYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >